首页 › 基金 › Verdad Advisers, LP › SGP

Verdad Advisers, LP 对 SGP 的持仓历史

SPYGLASS PHARMA INC · 医疗保健

Verdad Advisers, LP 在 Q3 2026 的 13F 申报中披露持有 SGP(SPYGLASS PHARMA INC)56,708 股,市值约 US$1.5M,约占其申报组合的 1.58%,在其申报持仓中市值排名第 8 位。 Verdad Advisers, LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)56.71K 股
申报持仓市值$1.47M
组合权重1.58%
首次申报Q3 2026
最近变动新进
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Verdad Advisers, LP 对 SGP 的持仓演变

Verdad Advisers, LP 于 Q3 2026 首次披露 SGP 持仓:56,708 股(约 US$1.5M)。

逐季持仓明细

季度股数金额变化
Q3 2026 56.71K $1.47M 新进

关于 SGP 与 13F 数据

SGP(SPYGLASS PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 74 只申报持有 SGP,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$178.6M), NEA Management Company, LLC (US$164.6M), Sands Capital Alternatives, LLC (US$65.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SGP 的基金

查看 SGP 的全部基金持有人 →

常见问题

How long has Verdad Advisers, LP held SGP?

Verdad Advisers, LP has disclosed SGP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Verdad Advisers, LP's current position in SGP?

As of Q3 2026, Verdad Advisers, LP holds 56.71K shares of SGP (SPYGLASS PHARMA INC), valued at $1.47M, representing 1.58% of its reported portfolio and ranking #8.

Has Verdad Advisers, LP been buying or selling SGP?

In the latest 13F filing (Q3 2026), Verdad Advisers, LP newly opened its position in SGP.

Which other funds hold SGP?

Other major institutional holders of SGP include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Sands Capital Alternatives, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.